Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks
Information source: The University of Texas Medical Branch, Galveston
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Burn
Intervention: Sulfamylon 5% and Silver Nitrate Soaks (Drug)
Phase: Phase 2/Phase 3
Status: Terminated
Sponsored by: The University of Texas Medical Branch, Galveston Official(s) and/or principal investigator(s): David N Herndon, MD, Principal Investigator, Affiliation: University of Texas
Summary
Determine effectiveness of various antimicrobial solutions on burn wounds (infections, wound
healing, length of hospital stay).
Clinical Details
Official title: Comparing the Use of Sulfamylon 5%, Dakins 0.025%, Cerium, Silver Nitrate 5% and/or Other Topical Antimicrobial Products for the Treatment of Excised and/or Grafted Burn Wounds
Study design: Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: Infection Rate
Secondary outcome: Length of Hospital Stay With Various Antimicrobial Solutions for Burn Patients
Detailed description:
Patients were treated with both Sulfamylon soaks and Silver nitrate soaks on different burn
areas. These two areas were then compared for incidence (percentage) of infections.
Eligibility
Minimum age: N/A.
Maximum age: 90 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Burn Injury requiring excisional therapy
- Hospitalization required until wounds are closed
Exclusion Criteria:
- Known hypersensitivity to products
- Outpatient treatment for burn injury
Locations and Contacts
University of Texas Medical Branch, Galveston, Texas 77555, United States
Additional Information
Starting date: July 1995
Last updated: December 10, 2012
|